---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-060173"
form_type: "8-K"
ticker: "ACRV"
cik: "0001781174"
company_name: "Acrivon Therapeutics, Inc."
filed_at: "2023-03-03T23:59:59+00:00"
generated_at: "2026-06-18T13:21:12.260501+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Acrivon Therapeutics sets 2023 annual meeting for June 22, 2023

## Summary
- First annual meeting of stockholders scheduled for June 22, 2023.
- Rule 14a-8 stockholder proposals must be received by March 13, 2023.
- Advance notice for director nominations and other proposals due by March 17, 2023.

## SEC filing metadata
- accession: 0001193125-23-060173
- form_type: 8-K
- ticker: ACRV
- cik: 0001781174
- company_name: Acrivon Therapeutics, Inc.
- filed_at: 2023-03-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781174/000119312523060173/0001193125-23-060173-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781174/000119312523060173/d444684d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-060173
- JSON: https://secwatch.observer/filing/0001193125-23-060173.json
- Plain text: https://secwatch.observer/filing/0001193125-23-060173.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.